1. Home
  2. VRTX vs CDNS Comparison

VRTX vs CDNS Comparison

Compare VRTX & CDNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vertex Pharmaceuticals Incorporated

VRTX

Vertex Pharmaceuticals Incorporated

HOLD

Current Price

$524.95

Market Cap

124.7B

Sector

Technology

ML Signal

HOLD

Logo Cadence Design Systems Inc.

CDNS

Cadence Design Systems Inc.

HOLD

Current Price

$373.31

Market Cap

106.8B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRTX
CDNS
Founded
1989
1988
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Computer Software: Prepackaged Software
Sector
Technology
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
124.7B
106.8B
IPO Year
2006
1994

Fundamental Metrics

Financial Performance
Metric
VRTX
CDNS
Price
$524.95
$373.31
Analyst Decision
Buy
Strong Buy
Analyst Count
29
14
Target Price
$539.69
$375.00
AVG Volume (30 Days)
1.5M
2.4M
Earning Date
05-04-2026
04-27-2026
Dividend Yield
N/A
N/A
EPS Growth
836.54
5.45
EPS
4.02
1.23
Revenue
$2,488,652,000.00
$5,296,759,000.00
Revenue This Year
$10.79
$16.00
Revenue Next Year
$10.47
$12.39
P/E Ratio
$131.43
$303.74
Revenue Growth
46.20
14.12
52 Week Low
$362.50
$262.75
52 Week High
$529.14
$416.69

Technical Indicators

Market Signals
Indicator
VRTX
CDNS
Relative Strength Index (RSI) 81.04 47.95
Support Level $422.12 $302.87
Resistance Level N/A $410.04
Average True Range (ATR) 13.62 13.25
MACD 6.11 -3.08
Stochastic Oscillator 98.77 32.23

Price Performance

Historical Comparison
VRTX
CDNS

About VRTX Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio, and Alyftrek for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex has diversified its portfolio through Casgevy, a gene-editing therapy for beta thalassemia and sickle-cell disease, and Journavx, a non-opioid pain medication approved for the treatment of moderate-to-severe acute pain in adults. Additionally, Vertex is evaluating small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.

About CDNS Cadence Design Systems Inc.

Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enables system-level analysis and verification solutions.

Share on Social Networks: